2003 PROXY

Company

LIGAND PHARMACEUTICALS INC

Filed

April 30, 2003

Period of Report

June 20, 2003

Accession Number

0000886163-03-000016

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →